Balkrishan (Simba) Gill, PhD till recently served as President, Chief Executive Officer and member of board of directors of Evelo Biosciences since September 2015. Dr. Gill has also served on the board of directors of Realm Therapeutics PLC since 2016, and as a Venture Partner at Flagship Pioneering, a life sciences innovation enterprise, since 2015. From 2006 to 2015, Dr. Gill served as the President and Chief Executive Officer of moksha8 Pharmaceuticals, Inc., a pharmaceutical company. Dr. Gill received his PhD from King’s College, London and his MBA from INSEAD.